文献速递心血管MR

扩张型心肌病弥漫性心肌纤维化的原生T1 mapping与细胞外容积mapping评估

Native T1 Mapping and Extracellular Volume Mapping for the Assessment of Diffuse Myocardial Fibrosis in Dilated Cardiomyopathy.
PubMed 文献 · JACC Cardiovasc Imaging · 2017-06-14

本研究在3-T下对36例扩张型心肌病患者行原生T1 mapping、增强后T1 mapping及延迟钆增强心脏磁共振,并以活检组织学为参考标准。结果显示原生T1与ECV均与活检证实的胶原容积分数显著相关,ECV与细胞外间隙成分强相关,原生T1与ECV在检测和定量胶原容积分数方面表现相当且可重复性高。

要点

  • 原生T1与ECV均与活检胶原容积分数显著相关(r分别为0.77和0.66,p<0.05)。
  • ECV与活检细胞外间隙成分强相关(r=0.86),原生T1仅中度相关(r=0.55)。
  • 原生T1和ECV的观察者间与观察者内可重复性分别为0.89、0.95、0.96、0.98。

核心结论

  • 原生T1在检测和定量组织学胶原容积分数方面与ECV表现相当且可重复性高,因此扩张型心肌病的弥漫性心肌纤维化可能无需钆对比剂即可通过原生T1 mapping可靠评估;ECV与组织学细胞外间隙高度一致。

研究设计与样本

  • 共纳入36例扩张型心肌病患者(31例男性,平均年龄56±16岁),在3-T下行增强前、后T1 mapping及延迟钆增强心脏磁共振,以活检样本经天狼星红染色定量胶原容积分数、经苏木精-伊红染色心肌定量细胞外间隙成分作为参考标准。

关键影像表现/征象

  • 36例患者中14例观察到非缺血性延迟钆增强。
  • 有延迟钆增强的患者活检证实的胶原容积分数显著高于无延迟钆增强者(21±12% vs. 11±8%,p<0.01),但两组间胶原容积分数值存在明显重叠。

诊断标准与关键数值

  • 原生T1值与活检证实的胶原容积分数显著相关(r=0.77,p<0.05)。
  • ECV与活检证实的胶原容积分数显著相关(r=0.66,p<0.05)。
  • ECV与活检证实的细胞外间隙成分强相关(r=0.86),原生T1与之仅中度相关(r=0.55)。
  • 原生T1和ECV的观察者间可重复性分别为0.89和0.96,观察者内可重复性分别为0.95和0.98。

临床应用与阅片要点

  • 在扩张型心肌病中,原生T1 mapping可在不使用钆对比剂的情况下评估弥漫性心肌纤维化。
  • 延迟钆增强阴性者仍可能存在与延迟钆增强阳性者重叠的胶原容积分数,仅凭延迟钆增强可能低估弥漫性纤维化。
  • ECV与组织学细胞外间隙成分的一致性优于原生T1。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The purpose of this study was to examine the histological correlation of native myocardial T1 and extracellular volume fraction (ECV) measurement at 3-T for the assessment of diffuse pathological changes in the myocardial tissue, including myocardial fibrosis and extracellular space in dilated cardiomyopathy (DCM).

BACKGROUND: Cardiac magnetic resonance T1 techniques allow the quantification of diffuse myocardial fibrosis. However, there are no definitive head-to-head studies of native T1 versus ECV for the detection, quantification, and characterization of pathological changes in the myocardial tissue in DCM by using histological samples for confirmation.

METHODS: A total of 36 subjects with DCM (31 men, mean age 56 ± 16 years) underwent pre- and post-contrast T1 mapping as well as late gadolinium enhancement (LGE) cardiac magnetic resonance at 3-T. Biopsy samples were used for the quantification of collagen volume fraction using picrosirius red staining and an extracellular space component from hematoxylin and eosin-stained myocardium.

RESULTS: Nonischemic LGE was observed in 14 of 36 patients. Although patients with LGE had significantly greater biopsy-proven collagen volume fraction than those without LGE (21 ± 12% vs. 11 ± 8%; p < 0.01), there was substantial overlap of collagen volume fraction values between patients with and without LGE. Both native T1 value and ECV were similarly and significantly associated with biopsy-proven collagen volume fraction (r = 0.77 and r = 0.66, respectively; p < 0.05). Furthermore, ECV had a strong correlation with the biopsy-proven extracellular space component (r = 0.86), whereas native T1 had only a moderate correlation (r = 0.55). Interobserver and intraobserver reproducibility for native T1 and ECV were 0.89, 0.95, 0.96, and 0.98, respectively.

CONCLUSIONS: Native T1 exhibited comparable ability as ECV measurement in the detection and quantification of histological collagen volume fraction, with high reproducibility, and therefore diffuse myocardial fibrosis in DCM may be reliably assessed by native T1 mapping without the administration of gadolinium contrast agent. In addition, cardiac magnetic resonance-derived ECV showed excellent agreement with histological extracellular space.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Nakamori S, Dohi K, Ishida M, et al. Native T1 Mapping and Extracellular Volume Mapping for the Assessment of Diffuse Myocardial Fibrosis in Dilated Cardiomyopathy. JACC Cardiovasc Imaging. 2017. PMID: 28624408. doi:10.1016/j.jcmg.2017.04.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。